ornithine has been researched along with Ischemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, RB; Fouda, AY; Lucas, R; McGee-Lawrence, ME; Morris, CA; Rusch, NJ; Shahror, RA; Shosha, E; Xu, Z | 1 |
| Garcia, JH; Gonçalves, ES; Guimarães, SB; Prado Neto, AX; Rabelo, CM; Vasconcelos, PR | 1 |
| Aydogdu, N; Erbas, H; Kaymak, K | 1 |
| Cerri, C; Fici, F; Scarlato, G | 1 |
| Müting, D | 1 |
| Persson, G | 1 |
| Bartkowski, S; Polaczek-Kornecki, T | 1 |
| Neiger, M | 1 |
1 review(s) available for ornithine and Ischemia
| Article | Year |
|---|---|
[Pathogenesis and treatment of portal encephalopathy].
Topics: Alkalosis; Alkalosis, Respiratory; Anti-Bacterial Agents; Arginine; Asparagine; Brain; Collateral Circulation; Diet Therapy; Dietary Proteins; Enema; Fructose; Galactose; Hepatic Encephalopathy; Humans; Hypertension, Portal; Ischemia; Liver Diseases; Memory Disorders; Mental Disorders; Neomycin; Nervous System Diseases; Neurologic Manifestations; Ornithine; Portacaval Shunt, Surgical | 1971 |
2 trial(s) available for ornithine and Ischemia
| Article | Year |
|---|---|
Ornithine-vasopressin (POR-8) as a vasoconstrictor in anesthetics used for ordinary dental treatment.
Topics: Adult; Anesthesia, Dental; Clinical Trials as Topic; Epinephrine; Female; Humans; Ischemia; Male; Mepivacaine; Microcirculation; Middle Aged; Ornithine; Pain; Regional Blood Flow; Time Factors; Vasopressins | 1971 |
[Clinical trial using POR 8 (Purantix-Sandoz) as vasoconstrictor. Its influence on blood pressure and pulse rate].
Topics: Anesthesia, General; Anesthesia, Local; Blood Pressure; Epinephrine; Frontal Sinus; Humans; Ischemia; Ornithine; Otosclerosis; Paranasal Sinuses; Pulse; Stapes Surgery; Tonsillectomy; Tympanoplasty; Vasoconstrictor Agents; Vasopressins | 1969 |
5 other study(ies) available for ornithine and Ischemia
| Article | Year |
|---|---|
The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury.
Topics: Animals; Arginase; Cytokines; Ischemia; Mice; Myeloid Cells; Ornithine; Ornithine Decarboxylase; Reperfusion Injury; Retinal Diseases; Tumor Necrosis Factor-alpha | 2023 |
Effect of short-term ornithine alpha-ketoglutarate pretreatment on intestinal ischemia-reperfusion in rats.
Topics: Animals; Calcium Carbonate; Disease Models, Animal; Intestinal Diseases; Intestine, Small; Ischemia; Lactic Acid; Ligation; Ornithine; Oxidative Stress; Pyruvic Acid; Random Allocation; Rats; Reperfusion Injury; Time Factors; Treatment Outcome | 2011 |
Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury.
Topics: Acetylcysteine; Animals; Arginase; Enzyme Activation; Female; Ischemia; Kidney; Nitric Oxide; Ornithine; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2004 |
alpha-Ketoglutarate induced transamination during ischemic exercise.
Topics: Adult; Amination; Ammonia; Citric Acid Cycle; Energy Metabolism; Humans; Ischemia; Ketoglutaric Acids; Lactates; Lactic Acid; Ornithine; Physical Exertion; Pyruvates; Pyruvic Acid | 1982 |
[The use of the preparation POR-8 (ornithine 8--vasopressin) as an ischemic drug in infiltration anesthesia with lignocaine].
Topics: Adolescent; Adult; Aged; Anesthesia, Local; Anesthetics; Humans; Ischemia; Lidocaine; Middle Aged; Ornithine; Peptides; Vasopressins | 1969 |